These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30816655)

  • 1. [Relapse in anxiety disorders].
    Muntingh ADT; Batelaan NM; van Balkom AJLM
    Ned Tijdschr Geneeskd; 2019 Feb; 163():. PubMed ID: 30816655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.
    Scholten WD; Batelaan NM; van Oppen P; Smit JH; Hoogendoorn AW; van Megen HJGM; Cath DC; van Balkom AJLM
    Psychother Psychosom; 2018; 87(4):240-242. PubMed ID: 29860251
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.
    Batelaan NM; Bosman RC; Muntingh A; Scholten WD; Huijbregts KM; van Balkom AJLM
    BMJ; 2017 Sep; 358():j3927. PubMed ID: 28903922
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression.
    Kim KH; Lee SM; Paik JW; Kim NS
    J Affect Disord; 2011 Jul; 132(1-2):121-9. PubMed ID: 21402412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.
    Nutt DJ
    J Clin Psychiatry; 2010; 71 Suppl E1():e02. PubMed ID: 20371029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of antidepressants in remitted anxiety disorder patients: the need for strategies to prevent relapse.
    Scholten WD; Batelaan NM; van Oppen P; Smit JH; van Balkom AJ
    Psychother Psychosom; 2013; 82(6):399-400. PubMed ID: 24080729
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?
    Hathaway EE; Walkup JT; Strawn JR
    Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):31-39. PubMed ID: 29337001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatments for depression in older people.
    Wilkinson P; Izmeth Z
    Cochrane Database Syst Rev; 2012 Nov; 11():CD006727. PubMed ID: 23152240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antidepressant medications in children and adolescents with non-obsessive-compulsive disorder anxiety disorders: a systematic assessment.
    Gentile S
    Expert Opin Drug Saf; 2014 Jun; 13(6):735-44. PubMed ID: 24845944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.
    Bosman RC; Huijbregts KM; Verhaak PF; Ruhé HG; van Marwijk HW; van Balkom AJ; Batelaan NM
    Br J Gen Pract; 2016 Oct; 66(651):e708-19. PubMed ID: 27528709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
    Llorca PM; Bodkin JA; Spann M; Ball SG; Russell JM; Ball SG
    J Clin Psychopharmacol; 2009 Feb; 29(1):96-7. PubMed ID: 19142122
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressant Prescribing by Pediatricians: A Mixed-Methods Analysis.
    Tulisiak AK; Klein JA; Harris E; Luft MJ; Schroeder HK; Mossman SA; Varney ST; Keeshin BR; Cotton S; Strawn JR
    Curr Probl Pediatr Adolesc Health Care; 2017 Jan; 47(1):15-24. PubMed ID: 28057447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians.
    Muntingh A; Batelaan N; Scholten W; van Balkom AJ
    J Psychiatry Neurosci; 2021 Jun; 46(3):E388-E389. PubMed ID: 34077149
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year outcome of elderly patients with anxious depression.
    Flint AJ; Rifat SL
    Psychiatry Res; 1997 Jan; 66(1):23-31. PubMed ID: 9061801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PURL: Antidepressant Tx for anxiety disorders: How long?
    McGuire P; Castelli G
    J Fam Pract; 2019 Sep; 68(7):409-410. PubMed ID: 31532817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Preventing Relapse in Adolescents With Depression and Anxiety.
    Cheung A
    J Am Acad Child Adolesc Psychiatry; 2023 Mar; 62(3):290-291. PubMed ID: 36566883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of anxiety disorders.
    Shelton CI
    J Am Osteopath Assoc; 2004 Mar; 104(3 Suppl 3):S2-5. PubMed ID: 15083990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.
    Serna MC; Real J; Cruz I; Galván L; Martin E
    BMC Public Health; 2015 Nov; 15():1184. PubMed ID: 26611468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.